Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric ClinicsNeonMind Biosciences Inc. an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today the appointment of Dr. Roumen Milev, MD, PhD, Clinical Lead of Providence …
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics
NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FSE:6UF) (“NeonMind” or the “Company”), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today the appointment of Dr. Roumen Milev, MD, PhD, Clinical Lead of Providence Care Hospital Interventional Psychiatry to its Specialty Clinics Advisory Board. Providence Care Hospital is one of Ontario’s leading providers of specialized care in aging, mental health, and rehabilitation and is fully affiliated with Queen’s University and St. Lawrence College, and an esteemed member of the Council of Academic Hospitals of Ontario, Canada
In his role on NeonMind’s Specialty Clinics Advisory Board, Dr. Milev will leverage his vast experience and success in setting up and managing interventional psychiatry clinics to support NeonMind as it develops its company-branded,...
Read Full Story: https://investingnews.com/news/psychedelics-investing/neonmind-appoints-ketamine-and-neurostimulation-expert-dr.roumen-milev-md-phd-to-specialty-clinic-advisory-board/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.